Henry Schein, Inc. (HSIC)
NASDAQ
Closed
Oct 9, 2026
Day's Range
83.4852 wk Range
61.95Overview - HSIC - Henry Schein, Inc.
Key Statistics
Valuation
Enterprise Value
14.84B
P/E (Trailing)
‪25.18‬
P/E (Forward)
‪14.41‬
PEG Ratio
‪1.48‬
Price / Sales (TTM)
‪0.72‬
Price / Book
‪3.06‬
EV / EBITDA
‪13.74‬
Profitability
Gross Margin
‪31.83%‬
Profit Margin
‪2.96%‬
Operating Margin
‪5.75%‬
Return on Assets
‪4.39%‬
Return on Equity
‪8.85%‬
Ownership
Shares Outstanding
111.91M
Float
91.71M
Short % of Shares Outstanding
‪8.22%‬
Held by Insiders
‪0.83%‬
Held by Institutions
‪112.27%‬
Price stats
Beta
‪0.81‬
50-Day Avg
‪87.80‬
200-Day Avg
‪80.04‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
16 analysts
Average price target
‪$ 98.19‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - HSIC - Henry Schein, Inc.
Peers - HSIC - Henry Schein, Inc.
Peer Comparison
Compared with companies in Medical Distribution listed on NASDAQ.
Profile Summary - HSIC - Henry Schein, Inc.
About
Henry Schein, Inc. is a health care solutions company that serves office-based dental, medical, and veterinary professionals. Henry Schein provides a broad range of products and services through its core businesses in healthcare distribution, specialty products, and technology-enabled value-added services. Its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
